Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial-Reference-Cited by-同舟云学术

Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial

Published:2024-07 Issue:5 Volume:8 Page:102468
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Research and Practice in Thrombosis and Haemostasis

Author:

Mittal Prabal^ORCID,Gafoor Rafael^ORCID,Sayar Zara^ORCID,Efthymiou Maria^ORCID,Tohidi-Esfahani Ibrahim^ORCID,Appiah-Cubi Stella,Arachchillage Deepa J.,Atkinson David^ORCID,Bordea Ekaterina^ORCID,Cardoso M. Jorge,Caverly Emilia,Chandratheva Arvind,Chau Marisa,Freemantle Nick,Gates Carolyn,Ja¨ger H. Rolf,Kaul Arvind^ORCID,Mitchell Chris,Nguyen Hanh,Packham Bunis,Paskell Jaye,Patel Jignesh P.^ORCID,Round Chris,Sanna Giovanni,Zaidi Abbas,Werring David J.,Isenberg David^ORCID,Cohen Hannah^ORCID

Funder

Versus Arthritis

LUPUS UK

Publisher

Elsevier BV

Reference37 articles.

1. Is stroke most common cause of disability?;Adamson;J Stroke Cerebrovasc Dis,2004

2. Systemic Lupus erythematosus: detailed anatomy of a cohort (follow-up for more than 35 years);Gracia-Tello;Arthritis Rheum,2016

3. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus;Ruiz-Irastorza;Arch Intern Med,2004

4. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality;Riancho-Zarrabeitia;Lupus,2020

5. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature;Andreoli;Arthritis Care Res,2013